181 related articles for article (PubMed ID: 1939101)
1. An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor.
Iwamoto R; Senoh H; Okada Y; Uchida T; Mekada E
J Biol Chem; 1991 Oct; 266(30):20463-9. PubMed ID: 1939101
[TBL] [Abstract][Full Text] [Related]
2. The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells.
Mitamura T; Iwamoto R; Umata T; Yomo T; Urabe I; Tsuneoka M; Mekada E
J Cell Biol; 1992 Sep; 118(6):1389-99. PubMed ID: 1522113
[TBL] [Abstract][Full Text] [Related]
3. Identification of diphtheria toxin receptor and a nonproteinous diphtheria toxin-binding molecule in Vero cell membrane.
Mekada E; Okada Y; Uchida T
J Cell Biol; 1988 Aug; 107(2):511-9. PubMed ID: 3417759
[TBL] [Abstract][Full Text] [Related]
4. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity.
Iwamoto R; Higashiyama S; Mitamura T; Taniguchi N; Klagsbrun M; Mekada E
EMBO J; 1994 May; 13(10):2322-30. PubMed ID: 8194524
[TBL] [Abstract][Full Text] [Related]
5. Purification of diphtheria toxin receptor from Vero cells.
Mekada E; Senoh H; Iwamoto R; Okada Y; Uchida T
J Biol Chem; 1991 Oct; 266(30):20457-62. PubMed ID: 1939100
[TBL] [Abstract][Full Text] [Related]
6. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
Shishido Y; Sharma KD; Higashiyama S; Klagsbrun M; Mekada E
J Biol Chem; 1995 Dec; 270(49):29578-85. PubMed ID: 7494001
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against Vero cells that protect against diphtheria toxin.
Rönnberg BJ; Lidgerding BC; Middlebrook JL
Toxicon; 1989; 27(10):1095-104. PubMed ID: 2815107
[TBL] [Abstract][Full Text] [Related]
8. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
Nakamura K; Iwamoto R; Mekada E
J Cell Biol; 1995 Jun; 129(6):1691-705. PubMed ID: 7790364
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria toxin receptor. Identification of specific diphtheria toxin-binding proteins on the surface of Vero and BS-C-1 cells.
Cieplak W; Gaudin HM; Eidels L
J Biol Chem; 1987 Sep; 262(27):13246-53. PubMed ID: 3654609
[TBL] [Abstract][Full Text] [Related]
10. Localization of the diphtheria toxin receptor-binding domain to the carboxyl-terminal Mr approximately 6000 region of the toxin.
Rolf JM; Gaudin HM; Eidels L
J Biol Chem; 1990 May; 265(13):7331-7. PubMed ID: 2332431
[TBL] [Abstract][Full Text] [Related]
11. Binding properties of diphtheria toxin to cells are altered by mutation in the fragment A domain.
Mekada E; Uchida T
J Biol Chem; 1985 Oct; 260(22):12148-53. PubMed ID: 4044590
[TBL] [Abstract][Full Text] [Related]
12. Evidence that membrane phospholipids and protein are required for binding of diphtheria toxin in Vero cells.
Olsnes S; Carvajal E; Sundan A; Sandvig K
Biochim Biophys Acta; 1985 Sep; 846(3):334-41. PubMed ID: 4041483
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotypic antibodies that protect cells against the action of diphtheria toxin.
Rolf JM; Gaudin HM; Tirrell SM; MacDonald AB; Eidels L
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2036-9. PubMed ID: 2467297
[TBL] [Abstract][Full Text] [Related]
14. Cellular regulation of diphtheria toxin cell surface receptors.
Rönnberg BJ; Middlebrook JL
Toxicon; 1989; 27(12):1377-88. PubMed ID: 2629178
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen.
Brown JG; Almond BD; Naglich JG; Eidels L
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8184-8. PubMed ID: 8367482
[TBL] [Abstract][Full Text] [Related]
16. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.
Mitamura T; Higashiyama S; Taniguchi N; Klagsbrun M; Mekada E
J Biol Chem; 1995 Jan; 270(3):1015-9. PubMed ID: 7836353
[TBL] [Abstract][Full Text] [Related]
17. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.
Greenfield L; Johnson VG; Youle RJ
Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria toxin can simultaneously bind to its receptor and adenylyl-(3',5')-uridine 3'-monophosphate.
Barbieri JT; Collins CM; Collier RJ
Biochemistry; 1986 Oct; 25(21):6608-11. PubMed ID: 3790545
[TBL] [Abstract][Full Text] [Related]
19. Entry of diphtheria toxin-protein A chimeras into cells.
Madshus IH; Stenmark H; Sandvig K; Olsnes S
J Biol Chem; 1991 Sep; 266(26):17446-53. PubMed ID: 1894632
[TBL] [Abstract][Full Text] [Related]
20. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.
Kageyama T; Ohishi M; Miyamoto S; Mizushima H; Iwamoto R; Mekada E
J Biochem; 2007 Jul; 142(1):95-104. PubMed ID: 17525101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
